Biocryst Pharmaceuticals, Inc. (NASDAQ: BCRX), Durham, NC – FDA Inspections
Inspection records and compliance data for Biocryst Pharmaceuticals, Inc. in Durham, North Carolina. 2 FDA inspections on record, last inspected May 05, 2017. Publicly traded as NASDAQ: BCRX.
This profile covers Biocryst Pharmaceuticals, Inc. based in Durham, North Carolina, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected June 26, 2009. Last inspected May 5, 2017.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| May 5, 2017 | NAI | Human Drugs · Bioresearch Monitoring | 1023509 |
| June 26, 2009 | NAI | Human Drugs · Bioresearch Monitoring | 596509 |
No Form 483s, Warning Letters or EIRs on record.
Companies with similar regulatory profiles, compliance history, and operations.
Name
Biocryst Pharmaceuticals, Inc.
Stock ticker
BCRX
Exchange
NASDAQ
Share price
$7.59
Market cap
$2.0B
Price as of
November 6, 2026
FEI Number
3009713274
Address
4505 Emperor Blvd Ste 200, Durham, North Carolina 27703, United States
Country
United States
ID: adfbc327-4431-4aa4-a13e-0c65fb2fb49f